Bacteria on the Rampage, Julian Davies, Nature, 9/19/96, pp. 219-220.
Directly Observed Therapy for Tuberculosis in Rural South Africa, 1991 through 1994, David Wilkinson et al, American Journal of Public Health, 8/96, p. 1094-7.
Directly Observed Therapy for Tuberculosis: The Harlem Hospital Experience, 1993, Wafaa El-Sadr, et al, American Journal of Public Health, 8/96, p. 1146.
High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens, J.E. LeClerc et al, Science, 11/165/96, p. 1208-9.
Infections Making a Deadly Comeback, L. Seachrist, Science News, 1/20/96, p. 38.
Investigators Seeking New Ways to Stem Rising Tide of Resistant Fungi, Joan Stephenson, JAMA 1/1/97, p. 5-6.
New Questions on Antibiotics for Ear Infection, Susan Gilbert, The New York Times, 11/27/96, p. C8.
Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone Family, Pablo Bifani et al, JAMA 2/14/96, p. 452-7.
Tuberculosis Control in Resource-Poor Settings with High Rates of Infection, Kevin de Cock, American Journal of Public Health, 8/96, p. 1071-3.
Virus X, Frank Ryan, Little, Brown and Co. New York, 1997. World Health Organization Strategy for Emerging Infectious Diseases, James LeDue, JAMA 1/24/96, pp. 318-20.
Electronic
The Alliance for the Prudent Use of Antibiotics thinks that safer is better than sorrier.
What does the FDA have to say about antibiotic resistance?
Here's the scoop on emerging infectious diseases.
How could evolutionary biology contribute to the fight against new killers?
Are new approaches needed? You bet.
Do your students want to do some real biology experiments?
The Why Files covered the influenza virus and microbes that destroy gasoline additives.
Sex and the single (malarial) parasite.
The Why Files covers the battle between evolution and creationism.
Need a primer on history of antimicrobial therapy?
